Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Esa Medika Mandiri Tbk. (EMMI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Esa Medika Mandiri Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Esa Medika Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Esa Medika Mandiri Tbk. trades at Rp348 (market cap 627.43B, 1.49M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Esa Medika Mandiri Tbk. is far larger — about 3.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Esa Medika Mandiri Tbk. is more actively traded (1.49M versus 324K). Which is the better fit depends on your goals.

EMMIOBAT
Market Cap
627.43B166.01B
Volume
1.49M324K
Lot
14.86K3.24K
Turnover
522.06M77.68M
Average Price
351.42239.75
Value
522.06M77.68M
Indicative Equilibrium Price
348240
Indicative Equilibrium Volume
1.55K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EMMI
View details
OBAT
View details

About Esa Medika Mandiri Tbk.

PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.

Read more on EMMI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT